Page last updated: 2024-09-05

sb 203580 and endomorphin 2

sb 203580 has been researched along with endomorphin 2 in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(endomorphin 2)
Trials
(endomorphin 2)
Recent Studies (post-2010) (endomorphin 2)
3,48941,1374430112

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)endomorphin 2 (IC50)
Delta-type opioid receptorMus musculus (house mouse)0.0482
Mu-type opioid receptorRattus norvegicus (Norway rat)0.001
Mu-type opioid receptorMus musculus (house mouse)0.0241

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, D; Fang, Q; Li, N; Qiu, Y; Xiao, J; Xu, B; Xu, K; Zhang, M; Zhang, N; Zhang, Q; Zhang, R; Zhang, T1

Other Studies

1 other study(ies) available for sb 203580 and endomorphin 2

ArticleYear
Spinal endomorphins attenuate burn-injury pain in male mice by inhibiting p38 MAPK signaling pathway through the mu-opioid receptor.
    European journal of pharmacology, 2021, Jul-15, Volume: 903

    Topics: Analgesics, Opioid; Animals; Behavior, Animal; Burns; Disease Models, Animal; Enzyme Inhibitors; Hyperalgesia; Imidazoles; Injections, Spinal; Male; Mice; Mice, Knockout; Narcotic Antagonists; Oligopeptides; p38 Mitogen-Activated Protein Kinases; Pain; Pyridines; Receptors, Opioid, mu; Signal Transduction; Spinal Cord Injuries

2021